Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Clinical trial NCT06088771 · RECRUITING

Trial details

NCT number: NCT06088771
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2024-10-09
Primary completion: 2026-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.